Search Results 1911-1920 of 17175 for rheumatoid arthritis
... factor-mediated biological effects. Clin Cancer Res. 2002 Apr; 8 (4):1242-50. View PubMed; Price DK, Ando Y, Kruger EA, Weiss M, Figg WD. 5'-OH-thalidomide, a ...
Anti-factor Xa Monitoring and Activated Charcoal for a Pediatric Patient With Rivaroxaban Overdose. Clin Pract Cases Emerg Med. 2018 Aug; 2 (3):247-250 Epub ...
The purpose of this study is to determine the effect of triple combination therapy with an anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor ...
Population attributable risk (PAR) is a function of time because both the prevalence of a risk factor and its effect on exposed individuals may change over ...
About this study. The purpose of this study is to see if the inflammation in early stage arthritis can be cessated by changing synoviocyte-macrophage ...
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never ...
... arthritis, Knee arthritis, Lumbar spondylosis, Spinal pain, Shoulder arthritis, Nerve irritation. Show more areas of focus for Nick C. Canzanello, D.O.. By ...
Patients taking anti-rheumatic disease medication (including methotrexate or other anti-metabolites) within the 3 months prior to study entry. Patients who ...
... arthritis. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site Map · About This Site. Legal Conditions and ...
... factor for late-onset AD . The lab has a number of approaches that aim to uncover the underlying genetics of LOAD . The details of these approaches and the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.